Related references
Note: Only part of the references are listed.Sirolimus versus cyclosporine in kidney recipients receiving Thymoglobulin®, mycophenolate mofetil and a 6-month course of steroids
M. Buechler et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2007)
Sirolimus modifies cholesterol Homeostasis in hepatic cells: A potential molecular mechanism for Sirolimus-Associated Dyslipidemia
Kun L. Ma et al.
TRANSPLANTATION (2007)
The unique character of cardiovascular disease in chronic kidney disease and its implications for treatment with lipid-lowering drugs
Joseph Nogueira et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2007)
Anti-atherosclerotic effects of sirolimus on human vascular smooth muscle cells
Kun L. Ma et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2007)
Kidney transplantation with sirolimus and mycophenolate mofetil-based immunosuppression: 5-year results of a randomized prospective trial compared to calcineurin inhibitor drugs
Stuart M. Flechner et al.
TRANSPLANTATION (2007)
Early withdrawal of calcineurin inhibitors and rescue immunosuppression with sirolimus-based therapy in renal transplant recipients with moderate to severe renal dysfunction
R. K. Wali et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2007)
Living related kidney transplantation without calcineurin inhibitors: Initial experience in a Mexican center
Gustavo Martinez-Mier et al.
TRANSPLANTATION (2006)
Generation of HSP60-specific regulatory T cell and effect on atherosclerosis
Keping Yang et al.
CELLULAR IMMUNOLOGY (2006)
A retrospective analysis of ezetimibe treatment in renal transplant recipients
C Buchanan et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2006)
Tacrolimus combined with two different dosages of sirolimus in kidney transplantation:: Results of a multicenter study
S Vitko et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2006)
Complete avoidance of calcineurin inhibitors in renal transplantation: A randomized trial comparing sirolimus and tacrolimus
TS Larson et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2006)
Apolipoprotein E genotypes as predictors of high-risk groups for developing hyperlipidemia in kidney transplant recipients undergoing sirolimus treatment
DG Maluf et al.
TRANSPLANTATION (2005)
Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins
C Baigent et al.
LANCET (2005)
Three-year efficacy and safety results from a study of everolimus versus mycophenolate mofetil in de novo renal transplant patients
S Vítko et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2005)
Everolimus versus mycophenolate mofetil in the prevention of rejection in de Novo renal transplant recipients: A 3-year randomized, multicenter, phase III study
MI Lorber et al.
TRANSPLANTATION (2005)
Effects of sirolimus on mesangial cell cholesterol homeostasis: a novel mechanism for its action against lipid-mediated injury in renal allografts
Z Varghese et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2005)
Treatment of hypercholesterolemia with ezetimibe in the kidney transplant population
JJ Puthenparumpil et al.
TRANSPLANTATION PROCEEDINGS (2005)
Randomized long-term trial of tacrolimus/sirolimus versus tacrolimus/mycophenolate mofetil versus cyclosporine (Neoral)/sirolimus in renal transplantation. II. Survival, function, and protocol compliance at 1 year
G Cianci et al.
TRANSPLANTATION (2004)
Absence of S6K1 protects against age- and diet-induced obesity while enhancing insulin sensitivity
SH Um et al.
NATURE (2004)
Everolimus (Certican) 12-month safety and efficacy versus mycophenolate mofetil in de novo renal transplant recipients
S Vitko et al.
TRANSPLANTATION (2004)
Predicting coronary heart disease in renal transplant recipients: A prospective study
D Ducloux et al.
KIDNEY INTERNATIONAL (2004)
Rapamycin attenuates atherosclerosis induced by dietary cholesterol in apolipoprotein-deficient mice through a p27 (Kip1)-independent pathway
C Castro et al.
ATHEROSCLEROSIS (2004)
Clinical practice guidelines for managing dyslipidemias in kidney transplant patients: a report from the Managing Dyslipidemias in Chronic Kidney Disease Work Group of the National Kidney Foundation Kidney Disease Outcomes Quality Initiative
B Kasiske et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2004)
A prospective randomized multicenter study of tacrolimus in combination with sirolimus in renal-transplant recipients.
JP van Hooff et al.
TRANSPLANTATION (2003)
Effect of fluvastatin on cardiac outcomes in renal transplant recipients:: a multicentre, randomised, placebo-controlled trial
H Holdaas et al.
LANCET (2003)
Safety and efficacy of sirolimus in kidney transplant patients and in patients with coronary artery disease undergoing angioplasty
HT Silva et al.
TRANSPLANTATION PROCEEDINGS (2003)
Protective effect of the immunosuppressant sirolimus against aortic atherosclerosis in apo E-deficient mice
MM Elloso et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2003)
Randomized trial of tacrolimus in combination with sirolimus or mycophenolate mofetil in kidney transplantation: Results at 6 months
T Gonwa et al.
TRANSPLANTATION (2003)
Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial-Lipid Lowering Arm (ASCOT-LLA):: a multicentre randomised controlled trial
PS Sever et al.
LANCET (2003)
Kidney transplantation without calcineurin inhibitor drugs: A prospective, randomized trial of sirolimus versus cyclosporin
SM Flechner et al.
TRANSPLANTATION (2002)
MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20536 high-risk individuals: a randomised placebo-controlled trial
R Collins et al.
LANCET (2002)
Effects of sirolimus on lipids in renal allograft recipients: An analysis using the Framingham risk model
CB Blum
AMERICAN JOURNAL OF TRANSPLANTATION (2002)
Effect of sirolimus on the metabolism of ApoB100-containing lipoproteins in renal transplant patients
RC Hoogeveen et al.
TRANSPLANTATION (2001)
Efficacy of sirolimus compared with azathioprine for reduction of acute renal allograft rejection: a randomised multicentre study
BD Kahan
LANCET (2000)
Hyperlipidaemia and post-heparin lipase activities in renal transplant recipients treated with sirolimus or cyclosporin A
ZA Massy et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2000)
Sirolimus in association with mycophenolate mofetil induction for the prevention of acute graft rejection in renal allograft recipients
H Kreis et al.
TRANSPLANTATION (2000)
Share Paper
